期刊文献+

苯妥英钠在血药浓度监测下治疗癫痫大发作与部分性发作73例临床观察 被引量:2

Clinical observation on 73 patients of the full and part break out of epilepsy with serum Phenytoin monitoring
暂未订购
导出
摘要 目的通过对苯妥英钠血药浓度的监测,观察苯妥英钠治疗73例癫痫患者的临床疗效。方法随机将本院门诊和住院收治的癫痫患者219例分为苯妥英钠(PHT)治疗组(n=73)、苯妥英钠(PHT)对照组(n=73)、苯妥英钠和苯巴比妥(PHT+PB)双药组(n=73),并对治疗组的患者进行治疗药物监测(TDM),双药组与对照组不进行TDM,观察其临床疗效。结果显示首次3组有效率差异无统计学意义(P>0.05),经调整DPH血药浓度后,3组疗效比较,治疗组与双药组、对照组有效率比较差异有统计学意义(P<0.05),双药组与对照组有效率比较差异无统计学意义(P>0.05)。结论表明控制癫痫大发作与部分性发作治疗组的个体化给药较双药组、对照组效果佳。 Objective To observe the clinical curative effect of Phenytoin sodium on 73 patients with epilepsy by monitoring of phenytoin sodium serum concentration. Methods Two hundred and nineteen patients were randomly divided into treated group (PHT, n = 73) and contrastive group (PHT, n = 73) and double medicines group (PHT+PB, n = 73) in our hospital outpatient service and be in hospital. The serum concentraction of therapeutic drug monitoring (TDM) were mes- dured in treated grorp. It was no measured in double medicines group and contrastive group, the clinical curative effect were observed. Results The effective rate of each group showed the difference was no statistically significant (P 〉 0.05). After abjusting the serum concentration of PHT, the effective rate of treated group showed the difference was statistically significant with the other two groups (P 〈 0.05), but double medicine group and contrastive group showed the difference was no statistically significant (P 〉 0.05). Conclusion It show that the control the full and part break out of epilepsy for individualized administration, the treated group is better then the double medicine group and contrastive group.
出处 《中国当代医药》 2012年第20期21-22,共2页 China Modern Medicine
关键词 癫痫 苯妥英钠 血药浓度 监测 Epilepsy Phenytoin Serum concentration Monitoring
  • 相关文献

参考文献8

二级参考文献17

  • 1李顺炜,毛名扬,李国忠,彭英.1990~2003年我院治疗药物监测结果回顾分析[J].安徽医药,2005,9(1):53-55. 被引量:7
  • 2钟建民,蔡兰云,李建华,陈勇,周末芝,卢庆红,吴华平.影响癫癎患儿苯巴比妥血药质量浓度的因素[J].实用儿科临床杂志,2005,20(11):1136-1138. 被引量:12
  • 3何大可,王丽,王寅初.治疗药物监测在抗癫痫药物临床治疗中的作用[J].中国医院药学杂志,2005,25(8):758-760. 被引量:15
  • 4任榕娜,黄铃沂,陈新民,叶礼燕,黄俊景.儿童癫癎丙戊酸用药个体化治疗观察[J].中国实用儿科杂志,2006,21(5):393-393. 被引量:12
  • 5Si DY,Guo YJ,Zhang YF,et al.Identification of a novel variant CYP2C9 allele in Chinese[J].Pharmacogenetics,2004,14(7):465-9.
  • 6Sanderson S,Emery J,Higgins J.CYP2C9 gene variants,drug dose,and bleeding risk in warfarin-treated patients:a HuGEnet systematic review and meta-analysis[J].Genet Med,2005,7(2):97-104.
  • 7WZ Wang, JZ Wu, DS Wang, et al. The Prevalence and Treatment Gap in Epilepsy in China:an ILAE/IBE/ WHO study [ J ]. Neurology,2003,60 (9) : 1544-1545.
  • 8Clovd JC, Ehatta S, Cao C, et al. Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy [ J ]. Epilepsy Res, 2003,53 (1) :19-27.
  • 9Daniel RT,Thomas SG,Thomas M.Role of surgery in pediatric epilepsy.Indian Pediatr,2007,44(4):263-273.
  • 10Chan K,Beran RC.Value of therapeutic drug level monitoring and unbound (free) levels.Seizure,2008,17:572-575.

共引文献853

同被引文献22

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部